<!doctype html>
<html lang="ko">
<head>
<meta charset="utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<title>Ï†ïÏã†ÏùòÌïô Ï†ÑÍ≥µÏùò ÍµêÏú°ÏûêÎ£å</title>
<style>
  :root{
    --bg:#f5f7fb; --border:rgba(17,24,39,.12);
    --text:#111827; --muted:#6b7280; --radius:16px;
    --shadow:0 10px 26px rgba(17,24,39,.10);
    --sans: ui-sans-serif, system-ui, -apple-system, "Apple SD Gothic Neo", "Noto Sans KR", Segoe UI, Roboto, Helvetica, Arial;
  }
  *{box-sizing:border-box}
  body{margin:0;font-family:var(--sans);color:var(--text);background:var(--bg);padding:18px}
  .frame{
    max-width:1200px;margin:0 auto;border:1px solid var(--border);border-radius:var(--radius);
    background: linear-gradient(180deg, rgba(255,255,255,.92), rgba(255,255,255,.78));
    box-shadow:var(--shadow);overflow:hidden
  }
  .hd{padding:12px 14px;border-bottom:1px solid var(--border);background:rgba(255,255,255,.75);
      display:flex;justify-content:space-between;gap:10px;align-items:center}
  .hd .title{font-weight:800;font-size:14px}
  .hd .meta{display:none;}
  .lesson{display:grid;grid-template-columns:1fr;gap:12px;padding:14px}
  @media (min-width:980px){.lesson{grid-template-columns:1fr 1fr}}
  .pane{
    border:1px solid var(--border);border-radius:14px;overflow:hidden;background:rgba(255,255,255,.75);
    min-height:480px;height:70vh;max-height:760px;
    display:flex;flex-direction:column
  }
  .pane-hd{padding:10px 12px;border-bottom:1px solid var(--border);background:rgba(255,255,255,.80);
           display:flex;justify-content:space-between;gap:10px;align-items:center}
  .pane-hd strong{font-size:13px}
  .pane-bd{padding:12px;flex:1 1 auto;min-height:0}
  .pane-bd.scrollable{overflow-y:auto;overflow-x:hidden}
  .iframe-wrap{position:relative;width:100%;aspect-ratio:16/9;border:1px solid var(--border);border-radius:12px;overflow:hidden;background:#000}
  .iframe-wrap iframe{position:absolute;inset:0;width:100%;height:100%;border:0}
  .content{white-space:pre-wrap;line-height:1.7;font-size:16px}
  .hint{font-size:12px;color:var(--muted);line-height:1.5}
  .media-controls{display:flex;gap:8px;flex-wrap:wrap;align-items:center;margin-bottom:10px}
  button{border:1px solid var(--border);background:rgba(17,24,39,.04);color:var(--text);padding:8px 10px;border-radius:10px;cursor:pointer;font-weight:700}
  button.primary{background:rgba(37,99,235,.12)}
  #mtype{display:none;}
</style>
</head>
<body>
<div class="frame">
  <div class="hd">
    <div class="title">Ï†ïÏã†ÏùòÌïô Ï†ÑÍ≥µÏùò ÍµêÏú°ÏûêÎ£å</div>
    <div class="meta"></div>
  </div>

  <div class="lesson">
    <div class="pane">
      <div class="pane-hd"><div><strong> </strong></div><span id="mtype">-</span></div>
      <div class="pane-bd" id="mediaHost"></div>
    </div>

    <div class="pane">
      <div class="pane-hd"><div><strong>Ïä§ÌÅ¨Î¶ΩÌä∏</strong></div><span class="small">14339 chars</span></div>
      <div class="pane-bd scrollable"><div class="content">How to Find SAINT TMS
Show: The Carlat Psychiatry Podcast by Pocket Psychiatry: A Carlat Podcast
Date: Dec 1, 2025
Duration: 16m
üîó Show Link
SAINT TMS is now available. We take a closer look at its record-breaking effect size. CME: Take the CME Post-Test for this Episode Published On: 12/01/2025 Duration: 16 minutes, 04 seconds Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
SPEAKER_1
Call it SNT, call it Saint, but who do you call when your patient needs this intervention for depression? Welcome to The Carlat Psychiatry Podcast, Keeping Psychiatry Honest Since 2003.
SPEAKER_3
I&#39;m Chris Aiken, the Editor-in-Chief of The Carlat Psychiatry Report.
SPEAKER_1
And I&#39;m Kellie Newsome, a psychiatric NP and a dedicated reader of every issue.
SPEAKER_3
Last week, we learned that S&amp;T TMS brings 80% of patients to full remission, even after three to seven failed antidepressant trials. But we still have questions like, how does it work? How long does it last? And how do you find it for your patients?
SPEAKER_1
Tms uses magnetic pulses to change the electrical rhythms of the brain. That&#39;s called neuromodulation. If you want a more poetic version of that, rewind to our November 3rd episode where Owen Muir compares it to music, good memories and psychotherapy. All of these things change the brain&#39;s rhythm in ways that change us. That can lead to new learning. And learning is what the brain is doing in Tms. It&#39;s learning how to not be depressed, or to not have OCD, or not want to smoke any more cigarettes. So when Nolan Williams set out to improve on this treatment, he looked back on how he learned as he crammed for college exams.
SPEAKER_4
We&#39;ve known for some time based off of space learning theory that you can&#39;t kind of load a bunch of information into the brain without breaks. The brain needs breaks in order to produce proteins to strengthen dendritic spines and make longer term effects. And so there&#39;s been basic science experiments showing you need about an hour to hour and a half in between each application of stimulation. It also works in learning experiments. So if you take somebody and you show them something and you wait about an hour and show it to them again, it&#39;s much more powerful than if you show it to them twice in a row in the same time period. And we kind of intuitively know this, like people know this. If you&#39;ve ever studied for hard tests in college or grad school or med school, what you learn is that you can&#39;t make a single note card and look at it 50 times and then stop. You need to make 60 note cards and you need to look at each one of them for a minute. And then you get back to the first note card an hour later because they really need time to re-experience it. And we know if you do stimulation, you can recapitulate this finding if you wait 15 minutes. You really get no change in cortical excitability. You got to wait longer to see that. And so that&#39;s the rearrangement in time that we worked on and kind of worked on the engineering around.
SPEAKER_1
By keeping the interval between treatments at one hour, Williams was mirroring the way that people learn, both at a psychological level and at the level of the neuron. It takes about an hour for the neurons to produce the proteins it needs to change in response to the magnetic pulses of TMS, a process called long-term potentiation. We spoke with Brandon Bensley who helped develop SNT.
SPEAKER_5
You know, one of the ways to really match that peak to the protein expression so you can actually build on potentiation is to do about an hour spacing. There&#39;s some wiggle room there. Yeah, you can do 90 minutes, but at that point, it&#39;s harder to fit in all the stimulation in a day. On the earlier end, maybe 40, I think even 30 would be like probably cut on the early side. But then you&#39;re in the situation where you&#39;re not really optimizing it. So, you know, we chose the peak of that. So, we can say, okay, well, you can fit in 10 sessions in a 12-hour shift, which is what technicians worked in the lab.
SPEAKER_3
Long-term potentiation is the building block of neuroplasticity, and it&#39;s triggered by the TMS pulses, remodeling dendrites, strengthening neuronal connections, increasing their sensitivity to neurotransmitters. At a cellular level, it means that the neurons are communicating better. At the patient level, your patient is likely to say that they are thinking clearer. TMS is not the only therapy that operates through long-term potentiation. We also see it with psilocybin, lithium, cognitive behavioral therapy, and aerobic exercise.
SPEAKER_1
Let&#39;s pause for a preview of the CME quiz for this episode. Earn CME for each episode through the link in the show notes. In a small clinical trial, what percent of patients stayed in recovery from depression after S&amp;T TMS using as needed maintenance treatments? A, 20%, B, 50%, C, 80%, D, 100%.
SPEAKER_3
Back in 2020, I interviewed Joe Goldberg, and he pointed out that we don&#39;t really know what to do for patients with high levels of treatment resistance, after, say, five or more antidepressants have failed. At that point, we had no placebo-controlled trials to guide us. S&amp;T TMS changes that, but how long do its benefits last? The Stanford Group is currently at work testing whether they can keep people well by delivering brief one-day treatments of S&amp;T TMS on an as-needed basis. The need here is determined by biometric monitoring. They created a kind of deluxe fitbit that measures daily steps and more. Heart rate, temperature, movements, sleep and activity patterns. These things correlate tightly with depression ratings. So, it&#39;s like getting a daily mood rating without any effort from the patient. If they see early warning signs of depression, they invite that patient in for a TMS booster. So far, they&#39;ve published one study of the approach. It lasted a year, enrolled 21 patients, and 100% of them stayed well with as-needed S&amp;T TMS. On average, they required a booster treatment about one day every month.
SPEAKER_1
This is all good news for difficult to treat depression, but how do you bring S&amp;T TMS to your patient? New S&amp;T centers are opening up every month, and you can find the updated list at magnusmed.com, M-A-G-N-U-S, med.com. As of November 2025, it is available in New Orleans, Louisiana, Carl Springs, Florida, Charleston, South Carolina, Charlotte, North Carolina, New York City, Iowa City, Little Rock, Arkansas, Seattle, Washington, and in seven California cities near San Diego, Los Angeles, and San Francisco.
SPEAKER_3
But you don&#39;t need to send everyone with difficult-to-treat depression to S&amp;T. When antidepressants don&#39;t work, consider regular TMS first. It is about twice as effective as augmentation with other meds like Aripiprazole. And regular TMS is more accessible than S&amp;T TMS. If the six-week treatment of regular TMS is too long, the FDA did just clear an accelerated protocol using Brainway&#39;s Deep TMS, and it lets patients cluster most of the treatment sessions in the first week, followed by a few treatments that are spaced out so that they don&#39;t have to take significant time off of work. This accelerated Deep TMS is like a mini version of S&amp;T TMS. And while the data looks good, it&#39;s not as strong as S&amp;T and hasn&#39;t been tested in as high a degree of treatment resistance. I mean, the treatment itself is probably not as strong or potent as S&amp;T. The data is still solid. This FDA clearance just came out, so it&#39;s going to take some time for insurers to start reimbursing accelerated Deep TMS.
SPEAKER_4
Hello?
SPEAKER_3
Hello?
SPEAKER_2
Yeah, this is Burkett.
SPEAKER_3
Okay, let&#39;s talk about psychiatry 3.0.
SPEAKER_4
Yeah, typically when I see a patient, they&#39;ve usually failed everything. In my view, they clearly have a circuit disorder that&#39;s locked in to the brain.
SPEAKER_1
That was Danny Carlat calling Nolan Williams in 2015 for his first Carlat interview. On that call, Dr. Williams laid out the case that we are entering psychiatry 3.0, where version 1.0 was psychoanalysis, 2.0 was pharmacotherapy, and version 3.0 is neuromodulation, the ability to change behavior with magnetic pulses that resync brain rhythms and reshape neural connections.
SPEAKER_3
Neuromodulation is a new method, and it has a PR problem. We touched on that in our interview with Owen Muir two weeks ago. At best, TMS is hard to understand. At worst, it is science fiction. And we recently lost one of its biggest proponents. As we were in the middle of this podcast series, Dr. Williams passed away on October 8th, 2025, at the age of 43. He didn&#39;t just lead the research. He tried to bring it within reach. He was a frequent guest on podcasts and TV shows, speaking to health care systems across the world and to insurers in the US to get Saint TMS covered.
SPEAKER_1
Nolan&#39;s family announced the cause of his death in the New York Times obituary. It was a preventable one, something that takes the lives of one in 8,000 physicians every year, and something that Nolan worked hard to prevent, suicide.
SPEAKER_3
Nolan touched many lives, as the many tributes from patients, friends, colleagues and students online testify. Besides TMS, he ran psychedelic trials of ibogaine for traumatic brain injury and addiction in veterans. His latest project was on hypnosis. He found that only one in five people are highly hypnotizable, and that we could learn from them, especially if we&#39;re trying to change habits that are hard to break, like smoking. Nolan found that TMS could induce hypnotic states, bringing the treatment back to psychiatry 1.0, as he would have put it, when Freud discovered psychoanalysis through his forays into hypnosis.
SPEAKER_1
Nolan left behind a wife and two children, and many students, colleagues and patients. You can support his legacy at nolanrwilliams.com. One of Nolan&#39;s goals was to make S&amp;T TMS available in the hospital, something we haven&#39;t achieved yet. It is only covered as an outpatient treatment in a hospital type setting, kind of like coverage for a partial hospital program. Nolan often began his lectures by commenting on this problem.
SPEAKER_4
So in psychiatry, the patient comes in to the outpatient psychiatrist&#39;s office and says, I&#39;ve been thinking about ending my life. I&#39;ve been researching ways to do it.
SPEAKER_1
Right?
SPEAKER_4
And so what does the psychiatrist do? Politely steps out of the room, calls the police. The police come, they handcuff the patient, put them in the back of a squad car and drive them to the emergency room. And then they&#39;re strip searched in place in a hall bed, waiting for a psych bed, in a psych unit. Right? Then when they get up there, they&#39;re told, we don&#39;t have any additional treatments for you beyond what was available as an outpatient. Unlike the rest of medicine and psychiatry, as you escalate the acuity of care, we can get into details, but on average you lose treatment options and there are no tests. And what&#39;s even more striking is that your suicide risk at discharges triple what it was for the rest of your life.
SPEAKER_3
That was Nolan in 2023. In one of his final media appearances on May 20th, 2025, with the Alan Hu Foundation, Nolan told the same story, but this time it had a more personal edge to it.
SPEAKER_4
If you&#39;re seeing your psychiatrist saying that you want to end your life, you end up being in a scenario where they too call the authorities, but instead of the ambulance coming to pick you up, you end up in the back of a squad car, at least in the state of California.
SPEAKER_3
As I thought about Nolan, I realized that many trailblazers who change psychiatry struggled with the same mental problems in themselves or in their close family, including Owen Muir, who was open about having bipolar disorder and whose own recovery from depression with accelerated TMS led him to work on the controlled trial that got this new FDA label for accelerated deep TMS out this year. The protocol we mentioned that speeds up the therapy by starting with four treatments a day.
SPEAKER_2
For people who&#39;ve lived with a specific kind of suffering, what you understand about your own suffering is likely to be different than what other people notice from the outside, which can lead to research questions that other people wouldn&#39;t come up with. And so you have the dual motivation of knowing what it&#39;s like to suffer and knowing something about how it might be better. And so it may be that individuals who&#39;ve lived through suffering are more motivated and more capable of asking the most interesting questions. And they may be more willing to place the huge bet of years to decades of their life on the answer to that question. And so I suspect those who have what we call lived experience might be actually the best people to answer questions if they happen to like research or be willing to subject themselves to clinical research. We&#39;d want every researcher to have a unique insight. And we want everyone to be relentless in the work that they do. But people who&#39;ve lived it know it can&#39;t wait.
SPEAKER_3
We&#39;re going to pick up there next week as we look at the lived experiences that expired other psychiatric revolutions like psychoanalysis, 12-step programs, lithium, light therapy, DBT, and even The Carlat Report.
SPEAKER_1
Dr. Aiken&#39;s new book, Difficult to Treat Depression, is now available in print and as an audiobook. And it covers three strategies that boost TMS&#39;s antidepressant effects by pairing it with cycloserine, a glutamatergic med that enhances learning, light therapy, or CBT. You will discover other novel therapies like celicoxib, minocycline, probiotics, how to use them, and how to de-prescribe the ones that aren&#39;t working.
SPEAKER_3
Audio excerpts in this podcast are from Nolan Williams&#39; lecture at the Mental Healthcare Innovation Summit, his interview with the Alan Hugh Foundation, and from The Carlat Report interviews with Nolan Williams, Brandon Bensley, and Owen Muir.</div></div>
    </div>
  </div>
</div>

<script>
  const raw = "https://player.vimeo.com/video/1149322502?h=4e90428f22&badge=0&autopause=0&player_id=0&app_id=58479";

  function normalizeMediaInput(raw){
    const s = (raw || "").trim();
    if (!s) return "";
    if (s.includes("<iframe") && s.includes("src=")){
      const m = s.match(/src\s*=\s*["']([^"']+)["']/i);
      if (m && m[1]) return m[1].replace(/&amp;/g, "&").trim();
    }
    return s;
  }

  const url = normalizeMediaInput(raw);

  function isAudioUrl(u){
    try{ const x=new URL(u); return /(\.mp3|\.m4a|\.ogg|\.wav|\.webm)$/i.test(x.pathname); }catch(e){ return false; }
  }

  function parseYouTubeId(u){
    try{
      const x=new URL(u);
      if(x.hostname.includes("youtu.be")) return x.pathname.replace("/","");
      if(x.hostname.includes("youtube.com")){
        const v=x.searchParams.get("v"); if(v) return v;
        const m=x.pathname.match(/\/shorts\/([^\/]+)/); if(m) return m[1];
        const e=x.pathname.match(/\/embed\/([^\/]+)/); if(e) return e[1];
      }
      return null;
    }catch(e){ return null; }
  }

  function parseVimeoInfo(u){
    try{
      const x=new URL(u);
      const isVimeoHost = /(^|\.)vimeo\.com$/i.test(x.hostname);
      if(!isVimeoHost) return null;
      const idMatch = x.pathname.match(/(?:\/video\/|\/)(\d+)(?:$|[\/?#])/);
      const id = idMatch ? idMatch[1] : null;
      if(!id) return null;
      const h = x.searchParams.get("h");
      return { id, h };
    }catch(e){ return null; }
  }

  function buildVimeoEmbedSrc(vm){
    const base = "https://player.vimeo.com/video/" + encodeURIComponent(vm.id);
    const p = new URLSearchParams();
    if(vm.h) p.set("h", vm.h);
    p.set("badge","0");
    p.set("autopause","0");
    p.set("player_id","0");
    p.set("app_id","58479");
    return base + "?" + p.toString();
  }

  function loadVimeoApi(){
    return new Promise((resolve)=>{
      if(window.Vimeo && window.Vimeo.Player) return resolve(true);
      const s=document.createElement("script");
      s.src="https://player.vimeo.com/api/player.js"; s.async=true;
      s.onload=()=>resolve(true);
      s.onerror=()=>resolve(false);
      document.head.appendChild(s);
    });
  }

  const host = document.getElementById("mediaHost");

  if(!url){
    host.innerHTML = '<div class="hint">ÎØ∏ÎîîÏñ¥ ÏûÖÎ†•Ïù¥ ÎπÑÏñ¥ ÏûàÏäµÎãàÎã§.</div>';
  }else{
    const yt = parseYouTubeId(url);
    const vm = parseVimeoInfo(url);

    host.innerHTML = `
      <div class="media-controls">
        <button class="primary" id="btnPlay">Ïû¨ÏÉù</button>
        <button id="btnStop">Ï†ïÏßÄ</button>
      </div>
      <div id="stage"></div>`;

    const stage = document.getElementById("stage");
    const btnPlay = document.getElementById("btnPlay");
    const btnStop = document.getElementById("btnStop");

    if(yt){
      stage.innerHTML = '<div class="iframe-wrap"><div id="ytMount" style="width:100%;height:100%"></div></div>';

      function loadYtApi(){
        return new Promise((resolve)=>{
          if(window.YT && window.YT.Player) return resolve(true);
          const prev = window.onYouTubeIframeAPIReady;
          window.onYouTubeIframeAPIReady = function(){ if(typeof prev==="function") prev(); resolve(true); };
          const s=document.createElement("script");
          s.src="https://www.youtube.com/iframe_api"; s.async=true;
          s.onerror=()=>resolve(false);
          document.head.appendChild(s);
        });
      }

      loadYtApi().then((ok)=>{
        if(!ok){
          stage.innerHTML = '<div class="iframe-wrap"><iframe src="https://www.youtube.com/embed/'+encodeURIComponent(yt)+'?rel=0&modestbranding=1" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" allowfullscreen></iframe></div>';
          btnPlay.onclick=()=>{};
          btnStop.onclick=()=>{};
          return;
        }
        const player = new YT.Player("ytMount", { videoId: yt, playerVars: { rel:0, modestbranding:1 } });
        btnPlay.onclick=()=>{ try{ player.playVideo(); }catch(e){} };
        btnStop.onclick=()=>{ try{ player.stopVideo(); }catch(e){} };
      });
    }
    else if(vm){
      const vmSrc = buildVimeoEmbedSrc(vm);
      stage.innerHTML =
        '<div class="iframe-wrap"><iframe id="vimeoFrame" src="'+ vmSrc +
        '" frameborder="0" allow="autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe></div>';

      loadVimeoApi().then((ok)=>{
        if(!ok){
          btnPlay.onclick=()=>{};
          btnStop.onclick=()=>{};
          return;
        }
        const frame = document.getElementById("vimeoFrame");
        const p = new Vimeo.Player(frame);
        btnPlay.onclick=()=>{ try{ p.play(); }catch(e){} };
        btnStop.onclick=async ()=>{ try{ await p.pause(); await p.setCurrentTime(0); }catch(e){} };
      });
    }
    else if(isAudioUrl(url)){
      stage.innerHTML = '<audio id="audioEl" controls preload="metadata" src="'+url.replace(/"/g,"&quot;")+'"></audio>';
      const a = document.getElementById("audioEl");
      btnPlay.onclick=()=>{ try{ a.play(); }catch(e){} };
      btnStop.onclick=()=>{ try{ a.pause(); a.currentTime=0; }catch(e){} };
    }
    else{
      stage.innerHTML = '<div class="iframe-wrap"><iframe src="'+url.replace(/"/g,"&quot;")+'"></iframe></div>';
      btnPlay.onclick=()=>{};
      btnStop.onclick=()=>{};
    }
  }
</script>
</body>
</html>